202 related articles for article (PubMed ID: 25462565)
1. Visualization of the human CD4⁺ T-cell response in humanized HLA-DR4-expressing NOD/Shi-scid/γc(null) (NOG) mice by retrogenic expression of the human TCR gene.
Takahashi T; Katano I; Ito R; Ito M
Biochem Biophys Res Commun; 2015 Jan; 456(1):219-24. PubMed ID: 25462565
[TBL] [Abstract][Full Text] [Related]
2. Induction of human humoral immune responses in a novel HLA-DR-expressing transgenic NOD/Shi-scid/γcnull mouse.
Suzuki M; Takahashi T; Katano I; Ito R; Ito M; Harigae H; Ishii N; Sugamura K
Int Immunol; 2012 Apr; 24(4):243-52. PubMed ID: 22402880
[TBL] [Abstract][Full Text] [Related]
3. The analysis of the functions of human B and T cells in humanized NOD/shi-scid/gammac(null) (NOG) mice (hu-HSC NOG mice).
Watanabe Y; Takahashi T; Okajima A; Shiokawa M; Ishii N; Katano I; Ito R; Ito M; Minegishi M; Minegishi N; Tsuchiya S; Sugamura K
Int Immunol; 2009 Jul; 21(7):843-58. PubMed ID: 19515798
[TBL] [Abstract][Full Text] [Related]
4. Transplantation of mouse HSCs genetically modified to express a CD4-restricted TCR results in long-term immunity that destroys tumors and initiates spontaneous autoimmunity.
Ha SP; Klemen ND; Kinnebrew GH; Brandmaier AG; Marsh J; Hangoc G; Palmer DC; Restifo NP; Cornetta K; Broxmeyer HE; Touloukian CE
J Clin Invest; 2010 Dec; 120(12):4273-88. PubMed ID: 21084750
[TBL] [Abstract][Full Text] [Related]
5. Humanized transgenic mice expressing HLA DR4-DQ3 haplotype: reconstitution of phenotype and HLA-restricted T-cell responses.
Chen Z; de Kauwe AL; Keech C; Wijburg O; Simpfendorfer K; Alexander WS; McCluskey J
Tissue Antigens; 2006 Sep; 68(3):210-9. PubMed ID: 16948641
[TBL] [Abstract][Full Text] [Related]
6. HLA-DR4 (DRB1*0401) transgenic mice expressing an altered CD4-binding site: specificity and magnitude of DR4-restricted T cell response.
Pan S; Trejo T; Hansen J; Smart M; David CS
J Immunol; 1998 Sep; 161(6):2925-9. PubMed ID: 9743354
[TBL] [Abstract][Full Text] [Related]
7. Retroviral transduction of lineage antigen-negative ((Lin−) cells: a valuable alternative for the generation of T cell receptor (TCR) retrogenic mice.
Viret C; Cresson C; Broccardo C; Guerder S
J Immunol Methods; 2012 Oct; 384(1-2):103-10. PubMed ID: 22867746
[TBL] [Abstract][Full Text] [Related]
8. Genetically modified human CD4(+) T cells can be evaluated in vivo without lethal graft-versus-host disease.
Ali R; Babad J; Follenzi A; Gebe JA; Brehm MA; Nepom GT; Shultz LD; Greiner DL; DiLorenzo TP
Immunology; 2016 Aug; 148(4):339-51. PubMed ID: 27124592
[TBL] [Abstract][Full Text] [Related]
9. Predominant development of mature and functional human NK cells in a novel human IL-2-producing transgenic NOG mouse.
Katano I; Takahashi T; Ito R; Kamisako T; Mizusawa T; Ka Y; Ogura T; Suemizu H; Kawakami Y; Ito M
J Immunol; 2015 Apr; 194(7):3513-25. PubMed ID: 25712215
[TBL] [Abstract][Full Text] [Related]
10. Systemic human T cell developmental processes in humanized mice cotransplanted with human fetal thymus/liver tissue and hematopoietic stem cells.
Joo SY; Chung YS; Choi B; Kim M; Kim JH; Jun TG; Chang J; Sprent J; Surh CD; Joh JW; Kim SJ
Transplantation; 2012 Dec; 94(11):1095-102. PubMed ID: 23222735
[TBL] [Abstract][Full Text] [Related]
11. An in vivo model of priming of antigen-specific human CTL by Mo-DC in NOD/Shi-scid IL2rgamma(null) (NOG) mice.
Inoue M; Senju S; Hirata S; Irie A; Baba H; Nishimura Y
Immunol Lett; 2009 Sep; 126(1-2):67-72. PubMed ID: 19682495
[TBL] [Abstract][Full Text] [Related]
12. Tumor necrosis factor promotes human T-cell development in nonobese diabetic/severe combined immunodeficient mice.
Samira S; Ferrand C; Peled A; Nagler A; Tovbin Y; Ben-Hur H; Taylor N; Globerson A; Lapidot T
Stem Cells; 2004; 22(6):1085-100. PubMed ID: 15536198
[TBL] [Abstract][Full Text] [Related]
13. Allelic exclusion and peripheral reconstitution by TCR transgenic T cells arising from transduced human hematopoietic stem/progenitor cells.
Giannoni F; Hardee CL; Wherley J; Gschweng E; Senadheera S; Kaufman ML; Chan R; Bahner I; Gersuk V; Wang X; Gjertson D; Baltimore D; Witte ON; Economou JS; Ribas A; Kohn DB
Mol Ther; 2013 May; 21(5):1044-54. PubMed ID: 23380815
[TBL] [Abstract][Full Text] [Related]
14. T cell receptor-negative thymocytes from SCID mice can be induced to enter the CD4/CD8 differentiation pathway.
Shores EW; Sharrow SO; Uppenkamp I; Singer A
Eur J Immunol; 1990 Jan; 20(1):69-77. PubMed ID: 1968394
[TBL] [Abstract][Full Text] [Related]
15. Antigen-specific immunomodulation for type 1 diabetes by novel recombinant antibodies directed against diabetes-associates auto-reactive T cell epitope.
Dahan R; Gebe JA; Preisinger A; James EA; Tendler M; Nepom GT; Reiter Y
J Autoimmun; 2013 Dec; 47():83-93. PubMed ID: 24090977
[TBL] [Abstract][Full Text] [Related]
16. Human CD4+ HLA-G+ regulatory T cells are potent suppressors of graft-versus-host disease in vivo.
Pankratz S; Bittner S; Herrmann AM; Schuhmann MK; Ruck T; Meuth SG; Wiendl H
FASEB J; 2014 Aug; 28(8):3435-45. PubMed ID: 24744146
[TBL] [Abstract][Full Text] [Related]
17. Differential effect of HLA class-I versus class-II transgenes on human T and B cell reconstitution and function in NRG mice.
Majji S; Wijayalath W; Shashikumar S; Pow-Sang L; Villasante E; Brumeanu TD; Casares S
Sci Rep; 2016 Jun; 6():28093. PubMed ID: 27323875
[TBL] [Abstract][Full Text] [Related]
18. HLA-A2-matched peripheral blood mononuclear cells from type 1 diabetic patients, but not nondiabetic donors, transfer insulitis to NOD-scid/γc(null)/HLA-A2 transgenic mice concurrent with the expansion of islet-specific CD8+ T cells.
Whitfield-Larry F; Young EF; Talmage G; Fudge E; Azam A; Patel S; Largay J; Byrd W; Buse J; Calikoglu AS; Shultz LD; Frelinger JA
Diabetes; 2011 Jun; 60(6):1726-33. PubMed ID: 21521873
[TBL] [Abstract][Full Text] [Related]
19. HLA-DPB1*05: 01-restricted WT1332-specific TCR-transduced CD4+ T lymphocytes display a helper activity for WT1-specific CTL induction and a cytotoxicity against leukemia cells.
Lin Y; Fujiki F; Katsuhara A; Oka Y; Tsuboi A; Aoyama N; Tanii S; Nakajima H; Tatsumi N; Morimoto S; Tamanaka T; Tachino S; Hosen N; Nishida S; Oji Y; Kumanogoh A; Sugiyama H
J Immunother; 2013 Apr; 36(3):159-70. PubMed ID: 23502763
[TBL] [Abstract][Full Text] [Related]
20. Mature mainstream TCR alpha beta+CD4+ thymocytes expressing L-selectin mediate "active tolerance" in the nonobese diabetic mouse.
Herbelin A; Gombert JM; Lepault F; Bach JF; Chatenoud L
J Immunol; 1998 Sep; 161(5):2620-8. PubMed ID: 9725264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
